Cardeas Pharma Obtains $2,991,213 New Funding Round

  • Feed Type
  • Date
    9/27/2012
  • Company Name
    Cardeas Pharma
  • Mailing Address
    2518 Eastlake Ave. E. Seattle, WA 98102
  • Company Description
    The company is a stealth mode pharmaceutical developer.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,991,213
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.